ES2140396T3 - Compuesto de tienodiazepina y su uso. - Google Patents

Compuesto de tienodiazepina y su uso.

Info

Publication number
ES2140396T3
ES2140396T3 ES91916944T ES91916944T ES2140396T3 ES 2140396 T3 ES2140396 T3 ES 2140396T3 ES 91916944 T ES91916944 T ES 91916944T ES 91916944 T ES91916944 T ES 91916944T ES 2140396 T3 ES2140396 T3 ES 2140396T3
Authority
ES
Spain
Prior art keywords
antidemential
cholecystokinin
useful
compound
inhibitory action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91916944T
Other languages
English (en)
Inventor
Yoichi Naka
Keiichiro Haga
Masahiro Hosoya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Application granted granted Critical
Publication of ES2140396T3 publication Critical patent/ES2140396T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

UN COMPUESTO DE TIENODIAZEPINA REPRESENTADO POR LA FORMULA GENERAL (I), UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, Y COMPOSICION FARMACEUTICA QUE LO CONTIENE: EN DONDE CADA SIMBOLO ES COMO SE DEFINE EN EL TEXTO DE LA ESPECIFICACION. EL COMPUESTO EJERCE UNA EXCELENTE ACCION INHIBIDORA SOBRE LA COLECISTOQUININA Y LA GASTRINA Y TIENE UNA ACTIVIDAD POTENTE Y PERSISTENTE PARA INHIBIR LA SECRECION DE LA ENZIMA PANCREATICA Y DEL ACIDO CLORHIDRICO EN EL ESTOMAGO. POR LO TANTO ES MUY UTIL COMO MEDICINA QUE ACTUA SOBRE EL SISTEMA NERVIOSO CENTRAL Y PERIFERICO Y COMO MEDICINA PARA LA PREVENCION O TRATAMIENTO DE ALTERACIONES PANCREATICAS Y ULCERAS GASTROINTESTINALES. ADEMAS ES UTIL COMO FARMACO ANTIDEMENCIAL PORQUE SE SUPONE QUE DESARROLLA UNA ACCION ANTIDEMENCIAL BASADA EN LA ACCION INHIBIDORA DE LA COLECISTOQUININA.
ES91916944T 1991-09-30 1991-09-30 Compuesto de tienodiazepina y su uso. Expired - Lifetime ES2140396T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002097285A CA2097285C (en) 1991-09-30 1991-09-30 Thienodiazepine compounds and their use
PCT/JP1991/001315 WO1993007152A1 (en) 1991-09-30 1991-09-30 Thienodiazepine compound and its use

Publications (1)

Publication Number Publication Date
ES2140396T3 true ES2140396T3 (es) 2000-03-01

Family

ID=25676237

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91916944T Expired - Lifetime ES2140396T3 (es) 1991-09-30 1991-09-30 Compuesto de tienodiazepina y su uso.

Country Status (8)

Country Link
US (1) US5439905A (es)
EP (1) EP0559891B1 (es)
KR (1) KR970002640B1 (es)
AT (1) ATE188702T1 (es)
CA (1) CA2097285C (es)
DE (1) DE69131907T2 (es)
ES (1) ES2140396T3 (es)
WO (1) WO1993007152A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022872A1 (fr) * 1993-03-30 1994-10-13 Yoshitomi Pharmaceutical Industries, Ltd. Inhibiteur d'adhesion cellulaire et compose a base de thienotriazolodiazepine
US5426185A (en) * 1993-11-22 1995-06-20 Merck & Co., Inc. Antiarrhythmic benzodiazepines
WO1995032963A1 (en) * 1994-06-01 1995-12-07 Yoshitomi Pharmaceutical Industries, Ltd. Thienylazole compound and thienotriazolodiazepine compound
ES2139933T3 (es) * 1994-08-18 2000-02-16 Merck & Co Inc 2,3-dihidro-1-(2,2,2-trifluoroetil)-2-oxo-5-fenil-1h-1,4-benzodiacepinas.
US5700797A (en) * 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
US5631251A (en) * 1995-06-07 1997-05-20 Merck & Co., Inc. 5-cyclopropyl-1,4 benzodiazepine-2-ones
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
US5726171A (en) * 1995-06-07 1998-03-10 Merck & Co Inc N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides
CA2222491A1 (en) * 1995-06-07 1996-12-19 Merck & Co., Inc. Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
CA2257948A1 (en) * 1996-06-28 1998-01-08 Merck & Co., Inc. Antiarrhythmic combinations of selective iks antagonists with beta-adenergic blocking agents
US5776930A (en) * 1996-06-28 1998-07-07 Merck & Company, Inc. Pharmaceutical preparation
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
WO2012151512A2 (en) 2011-05-04 2012-11-08 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9328117B2 (en) 2011-06-17 2016-05-03 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9624244B2 (en) 2012-06-06 2017-04-18 Constellation Pharmaceuticals, Inc. Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
CN106687463B (zh) 2014-06-20 2019-04-09 星座制药公司 一种乙酰胺类化合物的晶型
KR101675984B1 (ko) 2015-02-23 2016-11-14 한양대학교 에리카산학협력단 티에노디아제핀 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348523A4 (en) * 1987-12-22 1991-10-09 Yoshitomi Pharmaceutical Industries, Ltd. Thienodiazepine compounds and their medicinal use
JP2953045B2 (ja) * 1989-12-01 1999-09-27 吉富製薬株式会社 チエノジアゼピン化合物
IL96613A0 (en) * 1989-12-18 1991-09-16 Merck & Co Inc Pharmaceutical compositions containing benzodiazepine analogs

Also Published As

Publication number Publication date
US5439905A (en) 1995-08-08
EP0559891B1 (en) 2000-01-12
DE69131907T2 (de) 2000-06-15
ATE188702T1 (de) 2000-01-15
EP0559891A1 (en) 1993-09-15
KR970002640B1 (ko) 1997-03-07
EP0559891A4 (es) 1994-03-16
WO1993007152A1 (en) 1993-04-15
CA2097285A1 (en) 1993-03-31
CA2097285C (en) 2000-03-14
DE69131907D1 (de) 2000-02-17

Similar Documents

Publication Publication Date Title
ES2140396T3 (es) Compuesto de tienodiazepina y su uso.
AU649421B2 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
NO306403B1 (no) Nye sulfonamidopyrimidiner, anvendelse av dem og farmasöytiske preparater inneholdende dem
CA2109613A1 (en) Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
EP0348523A4 (en) Thienodiazepine compounds and their medicinal use
FI893433A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
NO304793B1 (no) nor-gallesyrederivater, og anvendelse av dem for fremstilling av legemiddel
BG104138A (en) 2-aminopyridines containing substituents with condensed rings as nos inhibitors
MX9308199A (es) Inhibidores de enzima.
NO985711L (no) Farmas°ytikum for behandling av neurologiske og neuropsykiatriske mangler
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
DK0506539T3 (da) heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
IE940326L (en) Benzimidazole derivatives substituted with a radical group¹and their use for inhibiting gastric acid secretion
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
CA2114727A1 (en) Quinoline Derivatives as Immunostimulants
ATE259823T1 (de) Tricyclische erythromycinderivate
DK0572635T3 (da) Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne
YU46998B (sh) Postupak za dobijanje derivata cefema i medjuproizvoda za iste
KR880009018A (ko) 3-l-피로글루타밀-l-티아졸리딘-4-카르복실산 및 이의 제법
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
ES2074332T3 (es) Derivados de polihidroxiciclopentano, su preparacion y su uso terapeutico.
FI942468A0 (fi) Kemialliset yhdisteet, niiden valmistus ja käyttö
FR2640969B1 (es)
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
DE69412612D1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 559891

Country of ref document: ES